| scholarly article | Q13442814 |
| P2093 | author name string | Patrick J Pagano | |
| William A Kuziel | |||
| Edward G Shesely | |||
| Oscar A Carretero | |||
| Xiao-Ping Yang | |||
| Maria A Cavasin | |||
| Yun-He Liu | |||
| Tang-Dong Liao | |||
| P2860 | cites work | Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 |
| NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
| The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats | Q30310851 | ||
| A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. | Q31935126 | ||
| Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. | Q33900223 | ||
| Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling | Q35019701 | ||
| Blockade of CCR2 ameliorates progressive fibrosis in kidney. | Q35102859 | ||
| A single pathway for the development of essential hypertension | Q35174269 | ||
| Hypertensive risk factors in kidney disease in African Americans | Q35178675 | ||
| Macrophages and the kidney | Q35741778 | ||
| Targeting the chemokine network in renal inflammation. | Q35833399 | ||
| Angiotensin II increases connective tissue growth factor in the kidney. | Q35843514 | ||
| Macrophages and progressive tubulointerstitial disease. | Q36192823 | ||
| Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases | Q36310340 | ||
| Renal and vascular hypertension-induced inflammation: role of angiotensin II. | Q36398041 | ||
| Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system | Q36548154 | ||
| Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II | Q36821496 | ||
| Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability | Q37361893 | ||
| The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. | Q40153047 | ||
| Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases | Q41166483 | ||
| Cloning of murine gp91phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line | Q41223671 | ||
| Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins | Q41340023 | ||
| Localization and functional properties of angiotensin II AT1 receptors in the kidney: focus on renomedullary interstitial cells | Q41695516 | ||
| Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts | Q42460384 | ||
| Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells | Q42480556 | ||
| Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats | Q43852739 | ||
| Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. | Q44201217 | ||
| A mouse model of angiotensin II slow pressor response: role of oxidative stress | Q44223952 | ||
| Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling | Q44826984 | ||
| Is hypertension an inflammatory disease? | Q45193117 | ||
| Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells | Q45219190 | ||
| Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. | Q45309041 | ||
| Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. | Q45873944 | ||
| Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. | Q46654159 | ||
| Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats | Q46655141 | ||
| Hypertensive nephrosclerosis in African Americans | Q46666495 | ||
| Angiotensin-converting enzyme inhibitors: a new mechanism of action. | Q46745865 | ||
| Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans | Q46840744 | ||
| Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure | Q46847907 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis | Q48577521 | ||
| Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. | Q54471089 | ||
| Diversity in Phenotype and Steroid Hormone Dependence in Dendritic Cells and Macrophages in the Mouse Uterus1 | Q57260849 | ||
| A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion | Q70281435 | ||
| Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat | Q70803375 | ||
| A noninvasive computerized tail-cuff system for measuring blood pressure in mice | Q72210808 | ||
| Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats | Q73951397 | ||
| CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension | Q74316940 | ||
| Angiotensin II, nitric oxide, and end-organ damage in hypertension | Q77635329 | ||
| The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid | Q79111319 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertension | Q95566669 |
| P304 | page(s) | 256-263 | |
| P577 | publication date | 2008-06-09 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension | |
| P478 | volume | 52 |
| Q28288942 | 20-HETE and blood pressure regulation: clinical implications |
| Q36085541 | A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. |
| Q33922718 | Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo. |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q53270271 | Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. |
| Q54355810 | Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats. |
| Q52693067 | Anti-Renal Fibrotic Effect of Exercise Training in Hypertension. |
| Q38225832 | Apelin/APJ system: a promising therapy target for hypertension |
| Q41593706 | Association of Elevated Serum Lipoprotein(a), Inflammation, Oxidative Stress and Chronic Kidney Disease with Hypertension in Non-diabetes Hypertensive Patients |
| Q43580765 | Association of elevated inflammatory and endothelial biomarkers with prehypertension among Mongolians in China |
| Q42948551 | Biomarkers of inflammation, endothelial dysfunction and insulin resistance in adults of Inner Mongolia, China |
| Q39377637 | C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration |
| Q53191263 | CCR5 deficiency does not reduce hypertensive end-organ damage in mice. |
| Q88024703 | CXCL1-CXCR2 lead monocytes to the heart of the matter |
| Q37322338 | Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake |
| Q28080433 | Crosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney disease |
| Q38959449 | Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury |
| Q34460993 | Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension |
| Q91793649 | Distinct Redox Signalling following Macrophage Activation Influences Profibrotic Activity |
| Q34482262 | Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice |
| Q34298068 | Downregulation of alpha7 nicotinic acetylcholine receptor in two-kidney one-clip hypertensive rats. |
| Q37594091 | Elevated systolic blood pressure in male GH transgenic mice is age dependent. |
| Q35217148 | Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease |
| Q92308460 | Ginsenoside Rg3 Attenuates Angiotensin II-Mediated Renal Injury in Rats and Mice by Upregulating Angiotensin-Converting Enzyme 2 in the Renal Tissue |
| Q58726638 | Hemodialysis-related changes in phenotypical features of monocytes |
| Q38948319 | Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension |
| Q38380871 | Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling |
| Q37350777 | Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease |
| Q42609824 | Inflammation, angiotensin II, and hypertension |
| Q38177167 | Innate immunity in hypertension |
| Q35787438 | Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats |
| Q33621916 | Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage |
| Q34357832 | Local angiotensin II aggravates cardiac remodeling in hypertension |
| Q35673479 | Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. |
| Q55280575 | Macrophage Depletion Lowered Blood Pressure and Attenuated Hypertensive Renal Injury and Fibrosis. |
| Q47368141 | Macrophages under pressure: the role of macrophage polarization in hypertension. |
| Q35622459 | N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus |
| Q33604039 | N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research |
| Q37931043 | Novel concepts in the genesis of hypertension: role of LOX-1. |
| Q34978108 | Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors |
| Q39018896 | Oxidative Stress and Hypertensive Diseases |
| Q35026662 | Potential renovascular hypertension, space missions, and the role of magnesium |
| Q37216851 | Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions |
| Q37711748 | QGQS Granule in SHR Serum Metabonomics Study Based on Tools of UPLC-Q-TOF and Renin-Angiotensin-Aldosterone System Form Protein Profilin-1. |
| Q34163731 | Reactive oxygen species, NADPH oxidases, and hypertension |
| Q52714210 | Renal Protective Effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) in Obese Rats on a High-Salt Diet. |
| Q34784051 | Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure |
| Q34143414 | Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity |
| Q38872059 | Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy |
| Q89305203 | Role of immune cells in hypertension |
| Q92373811 | Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage |
| Q35023420 | Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II |
| Q33889292 | SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension |
| Q47706847 | Salt, Hypertension, and Immunity. |
| Q60484091 | Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy |
| Q33690864 | Sexual dimorphism in the blood pressure response to angiotensin II in mice after angiotensin-converting enzyme blockade |
| Q59336990 | Sirtuin 3 deficiency aggravates contrast-induced acute kidney injury |
| Q36040675 | Smooth muscle protein 22 alpha-Cre is expressed in myeloid cells in mice. |
| Q42583014 | The Use of a Pure Native Collagen Dressing for Wound Bed Preparation Prior to Use of a Living Bi-layered Skin Substitute |
| Q37433886 | The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension |
| Q37209205 | The growth factor midkine regulates the renin-angiotensin system in mice |
| Q36389061 | The kallikrein-kinin system as a regulator of cardiovascular and renal function |
| Q37233020 | The pathophysiology of hypertension in systemic lupus erythematosus |
| Q34196923 | The role of 20-HETE in androgen-mediated hypertension |
| Q38747937 | The role of chemokines in hypertension and consequent target organ damage |
| Q39157390 | The role of macrophages in hypertension and its complications |
| Q57785309 | Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension |
| Q36981025 | Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension |
Search more.